Not until ml has some ability to identify and even handle edge cases. If you talk about animal testing for things like cosmetics, we’re probably ok if nothing

Not until ml has some ability to identify and even handle edge cases. If you talk about animal testing for things like cosmetics, we’re probably ok if nothing new gets introduced for a while. If, however, you’re looking at drug matter there’s a high risk without pre-human testing. Especially with a new target or mode of action. Possible that such edge cases could then be treated with more elaborate models, but edge cases still present a problem. There were antibody examples where primates had no problem while humans damn near died. Pharmaceutical advancement will be much slower and lawyers’ purses much heavier.